会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Anti-aggregatory agents for platelets
    • US5338725A
    • 1994-08-16
    • US906525
    • 1992-06-30
    • Iwao OjimaMasakatsu EguchiYoung-Im OhBarry S. Coller
    • Iwao OjimaMasakatsu EguchiYoung-Im OhBarry S. Coller
    • A61K38/00C07K7/02C07K14/75A61K37/02C07K7/06C07K7/08
    • C07K14/75C07K7/02A61K38/00
    • The present invention provides synthetic antiaggregatory agents for preventing inhibition of fibrinogen-platelet binding. These anti-aggregatory agents have the general formulas (1)-(5).H--[--(AA.sub.i).sub.i --R--G--D--(AA.sub.j).sub.j --].sub.n --Cx (1)[Ri--C(O)--R--G--D--(AA.sub.j).sub.j --].sub.n --CX (2)Cy--[--AA.sub.i).sub.i --R--G--D--(AA.sub.j).sub.i --].sub.n --Z (3)H--[--(AA.sub.i).sub.i --R--G--D--(AA.sub.j).sub.j --].sub.n --CZ--[--(AA.sub.k).sub.k --R--G--D--(AA.sub.l).sub.l --].sub.m --Z (4)[R.sub.1 --C(O)--R--G--D--(AA.sub.i).sub.i --].sub.n --CZ[--(AA.sub.j).sub.j ]--R--G--D--(AA.sub.k).sub.k --].sub.m --Z (5)in which: R=Arg; G=Gly; D=Asp; AA.sub.i, AA.sub.j, AA.sub.k and AA.sub.l = alpha-, beta- and omega-amino acid residues; (AA.sub.i).sub.i (AA.sub.j).sub.j =peptide chains having the same or different amino acid residues; (AA.sub.k).sub.k =peptide chains having the same or different amino acid residues; (AA.sub.l).sub.l =peptide chains having the same or different amino acid residues; i and j =integers 0-20; m =an integer 1-10; n=an integer 2-10; Cx =a conjugator bearing at least two amine residues in a molecule having 1-30 carbon atoms, i.e, diamines, triamines, tetramines, and polyamines, which can have other functional groups in the molecule; Cy =a conjugator bearing at least two carboxyl residues in a molecule having 1-30 carbon atoms, i.e., aliphatic, aromatic, heteroaromatic, cycloalkyl dicarboxylic acid, tricarboxylic acid, and polycarboxylic acid residues, which can have other functional groups in the molecule; Cz .sup.= a conjugator bearing at least one amine residue and one carboxyl residue in an aromatic or a cycloalkyl skeleton, having 1-30 carbon atoms, i.e., aromatic, heteroaromatic and cycloalkyl amino carboxylic acid, diamino carboxylic acid, diamino dicarboxylic acid, and ployamino polycarboxylic acid residues; R.sub.1 =an alkyl, aromatic, heteroaromatic, or cycloalkyl group having 1-30 carbons, which can have other functional groups in the molecule; and Z=carboxyl, amide, N-substituted amide, hydrazide, N-substituted hydrazide, or ester group.
    • 9. 发明授权
    • Chiral copper amine complexes
    • 手性铜胺配合物
    • US5134238A
    • 1992-07-28
    • US730001
    • 1991-07-15
    • Bryant E. RossiterMasakatsu Eguchi
    • Bryant E. RossiterMasakatsu Eguchi
    • C07C45/69C07F1/08C07F7/18
    • C07C45/69C07F1/08C07F7/1856C07F7/188
    • Disclosed herein is a class of chiral copper-amine complexes of the formula R(L*) CuLi in which L* is selected from: ##STR1## In this formula, R is a transferable ligand, which can be alkyl, aryl or aralkyl. M is a metal ion such as Li, Na, K, Cs, Rb, Be, Mg and other metal ions from the first two columns of the periodic table. R.sub.1 is straight chain alkyl, R.sub.2 is aryl or substituted aryl and R.sub.3 and R.sub.4 form a heterocyclic ring or a substituted heterocyclic ring with 4 to 8 members including oxygen and sulfur.Such complexes react with .alpha.,.beta.-unsaturated ketones, aldehydes, esters and other carbonyl containing compounds such that R is transferred to the 3 position enantioselectively as shown below. ##STR2## Such complexes react with .alpha.,.beta.-unsaturated ketones in the presence of trialkysilyl halides to give silyl enol ether in which R is substituted in the 3 position as shown below. ##STR3##
    • 本文公开了一类式R(L *)CuLi的手性铜胺配合物,其中L *选自:其中R是可转移的配体, 其可以是烷基,芳基或芳烷基。 M是周期表前两列的金属离子,如Li,Na,K,Cs,Rb,Be,Mg等金属离子。 R1是直链烷基,R2是芳基或取代的芳基,R3和R4形成杂环或具有4至8个成员的取代杂环,包括氧和硫。 这种络合物与α,β-不饱和酮,醛,酯和其它含羰基化合物反应,使得R如下所示以对映异构选择性转移到3位。 此类络合物在三烷基硅烷基卤存在下与α,β-不饱和酮反应,得到甲硅烷基烯醇醚,其中R 3在3位被取代,如下所示。
    • 10. 发明授权
    • Reverse-turn mimetics and method relating thereto
    • 反转模拟物及其相关方法
    • US08318738B2
    • 2012-11-27
    • US13194428
    • 2011-07-29
    • Sung Hwan MoonJae Uk ChungSung Chan LeeMasakatsu EguchiMichael KahnKwang Won JeongCu Nguyen
    • Sung Hwan MoonJae Uk ChungSung Chan LeeMasakatsu EguchiMichael KahnKwang Won JeongCu Nguyen
    • C07D487/04A61K31/53
    • C07D487/04
    • Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures have utility over a wide range of fields, including use as diagnostic and therapeutic agents. Libraries containing the reverse-turn mimetic structures of this invention are also disclosed as well as methods for screening the same to identify biologically active members. The invention also relates to the use of such compounds for inhibiting or treating disorders modulated by Wnt-signaling pathway, such as cancer, especially colorectal cancer, restenosis associated with angioplasty, polycystic kidney disease, aberrant angiogenesis disease, rheumatoid arthritis disease, tuberous sclerosis complex, Alzheimer's disease, excess hair growth or loss, or ulcerative colitis.
    • 公开了模拟生物活性肽和蛋白质的反转转区的二级结构的构象约束化合物。 这种反转模拟结构在广泛的领域中具有实用性,包括用作诊断和治疗剂。 还公开了包含本发明的反转模拟结构的文库以及用于筛选其的方法以鉴定生物活性成员。 本发明还涉及这种化合物用于抑制或治疗由Wnt信号传导途径调节的疾病,例如癌症,特别是结肠直肠癌,与血管成形术,多囊肾病,异常血管生成疾病,类风湿性关节炎疾病,结节性硬化综合征相关的再狭窄 ,阿尔茨海默氏病,过度毛发生长或损失,或溃疡性结肠炎。